Section one: Contracting authority/entity
one.1) Name and addresses
The Royal Marsden NHS Foundation Trusts
Harbour Yard
London
SW10 0XD
Contact
chelwest.tenders@nhs.net
Country
United Kingdom
NUTS code
UKI - London
Internet address(es)
Main address
https://www.royalmarsden.nhs.uk
Buyer's address
https://www.royalmarsden.nhs.uk
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Purchase of AAA Netspot - Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours
Reference number
DN535566
two.1.2) Main CPV code
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.1.3) Type of contract
Supplies
two.1.4) Short description
AAA Netspot is a Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £475,200
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKI - London
two.2.4) Description of the procurement
The Royal Marsden Hospital NHS Foundation Trust needs to purchase AAA Netspot vials which is a Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The procurement falls outside the scope of application of the regulations
Explanation:
AAA Netspot vials is a Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours. A radioactive diagnostic agent for positron emission tomography (PET) imaging of somatostatin receptor overexpression in adult patients with confirmed or suspected somatostatin receptor positive
neuroendocrine tumors (NETs) for localizing primary tumours and their metastases.
This innovative technology supports a more accurate diagnosis and staging of NETs and a more tailored treatment plan
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
Section five. Award of contract/concession
A contract/lot is awarded: Yes
five.2) Award of contract/concession
five.2.1) Date of conclusion of the contract
7 April 2021
five.2.2) Information about tenders
The contract has been awarded to a group of economic operators: Yes
five.2.3) Name and address of the contractor/concessionaire
Advance Accelerator Applications
London
NW1 5QT
Country
United Kingdom
NUTS code
- UKI - London
The contractor/concessionaire is an SME
No
five.2.3) Name and address of the contractor/concessionaire
Advance Accelerator Applications
London
Country
United Kingdom
NUTS code
- UKI - London
The contractor/concessionaire is an SME
No
five.2.4) Information on value of contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession: £475,200
Section six. Complementary information
six.4) Procedures for review
six.4.1) Review body
High Court
London
Country
United Kingdom